Comparing Pixie Dust Technologies (NASDAQ:PXDT) and Heyu Biological Technology (OTCMKTS:HYBT)

Heyu Biological Technology (OTCMKTS:HYBT) and Pixie Dust Technologies (NASDAQ:PXDT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation.

Insider and Institutional Ownership

0.4% of Pixie Dust Technologies shares are held by institutional investors. 89.2% of Heyu Biological Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Heyu Biological Technology and Pixie Dust Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heyu Biological Technology	0	0	0	0	N/A
Pixie Dust Technologies	0	0	1	0	3.00

Pixie Dust Technologies has a consensus price target of $5.21, indicating a potential upside of 100.38%. Given Pixie Dust Technologies’ higher probable upside, analysts clearly believe Pixie Dust Technologies is more favorable than Heyu Biological Technology.

Valuation and Earnings

This table compares Heyu Biological Technology and Pixie Dust Technologies’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heyu Biological Technology	$80,000.00	287.28	-$270,000.00	N/A	N/A
Pixie Dust Technologies	$5.18 million	7.38	-$14.45 million	N/A	N/A

Heyu Biological Technology has higher earnings, but lower revenue than Pixie Dust Technologies.

Profitability

This table compares Heyu Biological Technology and Pixie Dust Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heyu Biological Technology	-453.55%	-6.43%	-4.43%
Pixie Dust Technologies	N/A	N/A	N/A

Summary

Pixie Dust Technologies beats Heyu Biological Technology on 7 of the 10 factors compared between the two stocks.

About Heyu Biological Technology

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

About Pixie Dust Technologies

Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.